Factors influencing nanotechnology commercialization: an empirical analysis of nanotechnology firms in South Korea
Source abstract
Abstract
Nanotechnology is a representative emerging technology in an embryonic stage. Due to the continuous support provided by both the public and private sectors of many countries, nanotechnologies have increasingly been commercialized in a wide array of industries, but also produce many commercialization failures. Tackling this problem, we investigate key factors affecting the commercialization of nanotechnologies. Identifying key factors of nanotechnology commercialization through literature review and interview with CEOs, we collected data of 206 Korean nanotechnology-based companies, and analyzed the causal relationship between key factors and financial performance. Logistic and Tobit regression models are used. Overall, companies achieving successful commercialization hold some common characteristics including consistent exploratory R&D, governmental funding, and nano-instrument/energy/environment-related products. Also, the use of potentially toxic materials makes commercialization difficult even if the products are not toxic.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Technology Assessment and Management · Innovation Policy and R&D · Private Equity and Venture Capital
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (82)
Show source-provided references
1. Alvarez LH, Cervantes FJ (2011) (Bio)nanotechnologies to enhance environmental quality and energy production. J Chem Technol Biotechnol 86:1354–136310.1002/jctb.2697 ↗
2. Anastas P, Warner J (2000) Green chemistry: theory and practice. Oxford University Press, New York10.1093/oso/9780198506980.001.0001 ↗
3. Andersen M (2011) Silent innovation: corporate strategizing in early nanotechnology evolution. J Techol Trans 36(6):680–69610.1007/s10961-011-9215-x ↗
4. Benner MJ, Tushman ML (2003) Exploitation, exploration, and process management: the productivity dilemma revisited. A Manag Rev 28(2):238-256. http://www.jstor.org/stable/30040711 . Accessed 25 Jan 2013
5. Bhat JSA (2005) Concerns of new technology based industries—the case of nanotechnology. Technovation 25(5):457–46210.1016/j.technovation.2003.09.001 ↗
6. Brown MA, Berry LG, Goel RK (1991) Guidelines for successfully transferring government-sponsored innovations. Res Policy 20(2):121–14310.1016/0048-7333(91)90075-2 ↗
7. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ (2006) In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40(14):4374–438110.1021/es052069i ↗
8. Burri RV, Bellucci S (2008) Public perception of nanotechnology. J Nanopart Res 10:387–39110.1007/s11051-007-9286-7 ↗
9. Capon N, Farley JU, Hoenig S (1990) Determinants of financial performance: a meta-analysis. Manag Sci 36:1143–115910.1287/mnsc.36.10.1143 ↗
10. Cooper R, Kleinschmidt J (1995) Benchmarking the firm’s critical success factors in new product development. J Prod Innov Manag 12(2):374–39110.1016/0737-6782(95)00059-3 ↗
11. Crawley T (2007) Commercialization of Nanotechnology–Key Challenges. Workshop organised by Nanoforum, Helsinki
12. Dang Y, Zhang Y, Fan L, Chen H, Roco MC (2010) Trends in worldwide nanotechnology patent applications: 1991 to 2008. J Nanopart Res 12(3):687–70610.1007/s11051-009-9831-7 ↗
13. Darby ML, Zucker LG (2005) Grilichesian Breakthroughs: Inventions of Methods of Inventing and Firm Entry in Nanotechnology. NBER WORKING PAPER 9825. http://www.nber.org/papers/w9825 . Accessed 25 Jan 2013
14. Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA (2011) Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine 6:143–15610.2217/nnm.10.139 ↗
15. Ettlie JE (1982) The commercialization of federally sponsored technological innovations. Res Policy 11:173–19210.1016/0048-7333(82)90018-X ↗
16. Fritsch M, Lukas R (2001) Who cooperates on R&D? Res Policy 30(2):297–31210.1016/S0048-7333(99)00115-8 ↗
17. Geroski P, Machin S, Reenen JV (1993) The profitability of innovating firms. RAND J Econ 24(2):198–21110.2307/2555757 ↗
18. Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS (2008) Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 19(7):07510410.1088/0957-4484/19/7/075104 ↗
19. Greene W (1997) Econometric analysis. Prentice Hill, New Jersey
20. Gupta AK, Smith KG, Shalley CE (2006) The interplay between exploration and exploitation. Manag J 49(4):693–706
21. Hobson DW (2009) Commercialization of nanotechnology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(2):189–20210.1002/wnan.28 ↗
22. Hosmer DW, Lemeshow S (2000) Applied logistic regression. John Wiley & Sons, New York10.1002/0471722146 ↗
23. Huang C, Notten A, Rasters N (2011) Nanoscience and technology publications and patents: a review of social science studies and search strategies. J Technol Trans 36(2):145–17210.1007/s10961-009-9149-8 ↗
24. Hullmann A (2006) Who is winning the global nanorace? Nat Nanotechnol 1(2):81–8310.1038/nnano.2006.110 ↗
25. Hutchison JE (2008) Greener nanoscience: a proactive approach to advancing applications and reducing implications of nanotechnology. ACS Nano 2(3):395–40210.1021/nn800131j ↗
26. Islam N, Miyazaki K (2009) Nanotechnology innovation system: understanding hidden dynamics of nanoscience fusion trajectories. Technol Fore Soc Chang 76(1):128–14010.1016/j.techfore.2008.03.021 ↗
27. Jolly VK (1997) Commercializing new technologies: getting from mind to market. Harvard Business School, Boston
28. Kaiser D (2006) Notes Toward a Nanotech Timeline. OSTI Working Paper 6-06-001
29. Kalil TA (2005) Nanotechnology and the “valley of death”. Nanotech Law Bus 2(3):265-268. http://www.nanolabweb.com/index.cfm/action/main.default.viewArticle/articleID/90/CFID/5926816/CFTOKEN/17118368/index.html . Accessed 25 Jan 2013
30. Karen S (2007) Green Nanotechnology: It’s Easier Than You Think. Technical Report. Project on Emerging Nanotechnologies. http://eprints.internano.org/id/eprint/68 . Accessed 25 Jan 2013
31. Kasch S, Dowling M (2008) Commercialization strategies of young biotechnology firms: an empirical analysis of the US industry. Res Policy 37(10):1765–177710.1016/j.respol.2008.08.005 ↗
32. KISTI (2003, 2005, 2008, 2009), Korea Nanotechnology Annual. KISTI(Korea Institute of Science and Technology Information), Seoul
33. Klette TJ, Griliches Z (2000) Empirical patterns of firm growth and R&D investment: a quality ladder model interpretation. Econ J 110(463):363–38710.1111/1468-0297.00529 ↗
34. Knol WHC (2004) Micro and nanotechnology commercialization: balance between exploration and exploitation. Paper Presented at the MANCEF COMS2004 Conference, Edmonton
35. Kodama (1986) Technological diversification of Japanese industry. Sci Pub Policy 233:291–296
36. Kostoff RN, Koytcheff RG, Lau CGY (2007) Global nanotechnology research literature overview. Technol Fore Soc Chang 74(9):1733–174710.1016/j.techfore.2007.04.004 ↗
37. Lam C, James J, McCluskey R, Arepalli S, Hunter R (2006) A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36(3):189–21710.1080/10408440600570233 ↗
38. Laursen K, Salter A (2006) Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms. Strategy Manag J 27(2):131–15010.1002/smj.507 ↗
39. Lin BW, Lee Y, Hung SC (2006) R&D intensity and commercialization orientation effects on financial performance. J Bus Res 59(6):679–68510.1016/j.jbusres.2006.01.002 ↗
40. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B (2006) Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 40(14):4346–435210.1021/es060589n ↗
41. Ludhiyani A, Pathak R, Joshi S (2011) Business implications of recent developments in nanotechnology for micro scale devices. Int Econ 1(9):117–134. http://www.mruni.eu/lt/mokslo_darbai/ie/archyvas/dwn.php?id=277541 . Accessed 25 Jan 2013
42. Marchant GE, Sylvester DJ, Abbott KW (2008) Risk management principles for nanotechnology. Nano Eth 2(1):43–60
43. Maynard AD, Kuempel ED (2005) Airborne nanostructured particles and occupational health. J Nanopart Res 7(6):587–61410.1007/s11051-005-6770-9 ↗
44. McNeil RD, Lowe J, Mastroianni T, Cronin J, Ferk D (2007) Barriers to nanotechnology commercialization. A final report prepared for US Department of Commerce. The University of Illinois at Springfield. http://www.ntis.gov/pdf/Report-BarriersNanotechnologyCommercialization.pdf . Accessed 25 Jan 2013
45. Morbey GK, Reithner RM (1990) How R&D affects sales growth, productivity and profitability. Res Technol Manag 33(3):11–1510.1080/08956308.1990.11670656 ↗
46. Morris J, Willis J, Martinis DD, Hansen B, Laursen H, Sintes JR, Kearns P, Gonzalez M (2011) Science policy considerations for responsible nanotechnology decisions. Nat Nanotech 6(5):73–7710.1038/nnano.2010.191 ↗
47. Motoyama Y, Eisler MN (2011) Bibliometry and nanotechnology: a meta-analysis. Tech Fore Soc Chang 78(7):1174–118210.1016/j.techfore.2011.03.013 ↗
48. Nikulainen T, Palmberg C (2010) Transferring science-based technologies to industry-does nanotechnology make a difference? Technovation 30(1):3–1110.1016/j.technovation.2009.07.008 ↗
49. No HJ, Park Y (2010) Trajectory patterns of technology fusion: trend analysis and taxonomical grouping in nanobiotechnology. Tech Fore Soc Chang 77(1):63–7510.1016/j.techfore.2009.06.006 ↗
50. Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH (2009) Nanotoxicology: characterizing the scientific literature, 2000–2007. J Nanopart Res 11:251–25710.1007/s11051-008-9579-5 ↗
51. Palmberg C (2008) The transfer and commercialisation of nanotechnology: a comparative analysis of university and company researchers. J Technol Trans 33(6):631–65210.1007/s10961-007-9059-6 ↗
52. Palmberg C, Dernis H, Miguet C (2009) Nanotechnology: An overview based on indicators and statistics. OECD, STI WorkingPaper 7
53. Panyala NR, Pena-Mendez EM, Havel J (2008) Silver or silver nanoparticles: a hazardous threat to the environment and human health?. J Appl Biome 6(3):117–129. http://www.doaj.org/doaj?func=fulltext&passMe=http://www.zsf.jcu.cz/jab/6_3/havel.pdf . Accessed 25 Jan 201310.32725/jab.2008.015 ↗
54. Paull R, Wolfe J, Hebert P, Sinkula M (2003) Investing in nanotechnology. Nat Biotechnol 21(10):1144–114710.1038/nbt1003-1144 ↗
55. Pitkethly MJ (2004) Nanomaterials—the driving force. Mater Today 7(12):20–2910.1016/S1369-7021(04)00627-3 ↗
56. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3(7):423–42810.1038/nnano.2008.111 ↗
57. Porter AL, Youtie J (2009) How interdisciplinary is nanotechnology? J Nanopart Res 11(5):1023–104110.1007/s11051-009-9607-0 ↗
58. Porter AL, Youtie J, Shapira P, Schoeneck DJ (2008) Refining search terms for nanotechnology. J Nanopart Res 10(5):715–72810.1007/s11051-007-9266-y ↗
59. Priest SH, Greenhalgh T (2011) Nanotechnology as an experiment in democracy: how do citizens form opinions about technology and policy? J Nanopart Res 13:1521–1531. doi: 10.1007/s11051-011-0229-y10.1007/s11051-011-0229-y ↗
60. Rasmussen B (2007) Is the commercialization of nanotechnology different? A case study approach. Inno-Manag Pol Prac 9(1):62–7810.5172/impp.2007.9.1.62 ↗
61. Renn O, Roco MC (2006) Nanotechnology and the need for risk governance. J Nanopart Res 8(2):153–19110.1007/s11051-006-9092-7 ↗
62. Roco MC (2004) Nanoscale science and engineering: unifying and transforming tools. AIChE J 50(5):890–89710.1002/aic.10087 ↗
63. Roco MC (2005) Environmentally Responsible Development of Nanotechnology. Environ Sci Technol 39(5):106A–112A10.1021/es053199u ↗
64. Roco MC (2007) National nanotechnology initiative-past, present, future. In: Handbook of Nanoscience, Engineering and Technology, 2nd edn. Taylor and Francis, Oxford10.1201/9781420007848.ch3 ↗
65. Roco MC (2011) The long view of nanotechnology development: the National nanotechnology initiative at 10 years. J Nanopart Res 13(2):427–44510.1007/s11051-010-0192-z ↗
66. Roco MC, Bainbridge WS (2002) Converging technologies for improving human performance: integrating from the nanoscale. J Nanopart Res 4(4):281–29510.1023/A:1021152023349 ↗
67. Roco MC, Mirkin CA, Hersam MC (2010) Nanotechnology research directions for societal needs in 2020. Springer, New York
68. Ronteltap A, Fischer ARH, Tobi H (2011) Societal response to nanotechnology: converging technologies–converging societal response research? J Nanopart Res 13(10):4399–441010.1007/s11051-011-0473-1 ↗
69. Rosenberg N (1976) Perspectives on technology. Cambridge University Press, Cambridge10.1017/CBO9780511561313 ↗
70. Rothaermel FT, Thursby M (2007) The nanotech versus the biotech revolution: sources of productivity in incumbent firm research. Res Policy 36(6):832–84910.1016/j.respol.2007.02.008 ↗
71. Rothen-Rutishauser BM, Schürch S, Haenni B, Kapp N, Gehr P (2006) Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40(14):4353–435910.1021/es0522635 ↗
72. Schnaars S, Wymbs C (2004) On the persistence of lackluster demand the history of the video telephone. Technol Fore Soc Chang 71(3):197–21610.1016/S0040-1625(02)00410-9 ↗
73. Shapira P, Wang J (2009) From lab to market? strategies and issues in the commercialization of nanotechnology in China. Asi Bus Manag 8(4):461–48910.1057/abm.2009.15 ↗
74. Shapira P, Youtie J, Kay L (2011) National innovation systems and the globalization of nanotechnology innovation. J Technol Trans 36(6):587–60410.1007/s10961-011-9212-0 ↗
75. Sheetz T, Vidal J, Pearson TD, Lozano K (2005) Nanotechnology: awareness and societal concerns. Technol Soc 27(3):329–34510.1016/j.techsoc.2005.04.010 ↗
76. Shin DH (2007) Potential user factors driving adoption of IPTV. What are customers expecting from IPTV? Technol Fore Soc Chang 74(8):1446–146410.1016/j.techfore.2006.05.007 ↗
77. Smith GB, Granqvist CG, Lakhtakia A (2011) Green nanotechnology: solutions for sustainability and energy in the built environment. J Nanophoton 5(1):050201. doi: 10.1117/1.356298010.1117/1.3562980 ↗
78. So DS, Kim CW, Chung PS, Jhon MS (2012) Nanotechnology policy in Korea for sustainable growth. J Nanopart Res 14:85410.1007/s11051-012-0854-0 ↗
79. Walsh PR (2012) Innovation nirvana or innovation wasteland? Identifying commercialization strategies for small and medium renewable energy enterprises. Technovation 32(1):32–4210.1016/j.technovation.2011.09.002 ↗
80. Wang WY, Chang C (2005) Intellectual capital and performance in causal models: evidence from the information technology industry in Taiwan. J Intellect Cap 6(2):222–23610.1108/14691930510592816 ↗
81. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van de Meent D, Dekkers S, De Jong WH, Van Zijverden M, Sips AJAM, Geertsma RE (2009) Nano-silver—a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3(2):109–13810.1080/17435390902725914 ↗
82. Youtie J, Iacopetta M, Graham S (2008) Assessing the nature of nanotechnology: can we uncover an emerging general purpose technology? J Technol Trans 33(3):315–32910.1007/s10961-007-9030-6 ↗